284 related articles for article (PubMed ID: 7493554)
21. Metabolic activation of diclofenac by human cytochrome P450 3A4: role of 5-hydroxydiclofenac.
Shen S; Marchick MR; Davis MR; Doss GA; Pohl LR
Chem Res Toxicol; 1999 Feb; 12(2):214-22. PubMed ID: 10027801
[TBL] [Abstract][Full Text] [Related]
22. Cytochrome P4503A is the major source of N-vinylprotoporphyrin IX formation after administration of 3-[2-(2,4,6-trimethylphenyl)thioethyl]-4-methylsydnone to untreated and dexamethasone-pretreated rats.
McNamee JP; Marks GS
Drug Metab Dispos; 1996 Aug; 24(8):872-8. PubMed ID: 8869822
[TBL] [Abstract][Full Text] [Related]
23. Role of flavin-dependent monooxygenases and cytochrome P450 enzymes in the sulfoxidation of S-methyl N,N-diethylthiolcarbamate.
Madan A; Parkinson A; Faiman MD
Biochem Pharmacol; 1993 Dec; 46(12):2291-7. PubMed ID: 8274163
[TBL] [Abstract][Full Text] [Related]
24. Identification of the human P-450 enzymes responsible for the sulfoxidation and thiono-oxidation of diethyldithiocarbamate methyl ester: role of P-450 enzymes in disulfiram bioactivation.
Madan A; Parkinson A; Faiman MD
Alcohol Clin Exp Res; 1998 Sep; 22(6):1212-9. PubMed ID: 9756035
[TBL] [Abstract][Full Text] [Related]
25. Competitive inhibition of human liver microsomal cytochrome P450 3A-dependent steroid 6 beta-hydroxylation activity by cyclophosphamide and ifosfamide in vitro.
Murray M; Butler AM; Stupans I
J Pharmacol Exp Ther; 1994 Aug; 270(2):645-9. PubMed ID: 8071856
[TBL] [Abstract][Full Text] [Related]
26. Loss of rat liver microsomal cytochrome P-450 during methimazole metabolism. Role of flavin-containing monooxygenase.
Kedderis GL; Rickert DE
Drug Metab Dispos; 1985; 13(1):58-61. PubMed ID: 2858378
[TBL] [Abstract][Full Text] [Related]
27. Involvement of CYP3A1, 2B1, and 2E1 in C-8 hydroxylation and CYP 1A2 and flavin-containing monooxygenase in N-demethylation of caffeine; identified by using inducer treated rat liver microsomes that are characterized with testosterone metabolic patterns.
Chung WG; Roh HK; Kim HM; Cha YN
Chem Biol Interact; 1998 May; 113(1):1-14. PubMed ID: 9630843
[TBL] [Abstract][Full Text] [Related]
28. In vitro formation of an inhibitory complex between an isosafrole metabolite and rat hepatic cytochrome P-450 PB-B.
Murray M; Reidy GF
Drug Metab Dispos; 1989; 17(4):449-54. PubMed ID: 2571488
[TBL] [Abstract][Full Text] [Related]
29. Participation of P450 3A enzymes in rat hepatic microsomal retinoic acid 4-hydroxylation.
Martini R; Murray M
Arch Biochem Biophys; 1993 May; 303(1):57-66. PubMed ID: 8489266
[TBL] [Abstract][Full Text] [Related]
30. Rat liver cytochrome P450 metabolism of N-acetylbenzidine and N,N'-diacetylbenzidine.
Lakshmi VM; Zenser TV; Davis BB
Drug Metab Dispos; 1997 Apr; 25(4):481-8. PubMed ID: 9107548
[TBL] [Abstract][Full Text] [Related]
31. Participation of cytochromes P4502B and P4503A in cocaine toxicity in rat hepatocytes.
Poet TS; McQueen CA; Halpert JR
Drug Metab Dispos; 1996 Jan; 24(1):74-80. PubMed ID: 8825193
[TBL] [Abstract][Full Text] [Related]
32. Role of human microsomal and human complementary DNA-expressed cytochromes P4501A2 and P4503A4 in the bioactivation of aflatoxin B1.
Gallagher EP; Wienkers LC; Stapleton PL; Kunze KL; Eaton DL
Cancer Res; 1994 Jan; 54(1):101-8. PubMed ID: 8261428
[TBL] [Abstract][Full Text] [Related]
33. The effect of spironolactone treatment on the cytochrome P450-mediated metabolism of the pyrrolizidine alkaloid senecionine by hepatic microsomes from rats and guinea pigs.
Chung WG; Buhler DR
Toxicol Appl Pharmacol; 1994 Aug; 127(2):314-9. PubMed ID: 8048076
[TBL] [Abstract][Full Text] [Related]
34. Hepatic microsomal metabolism of the anthelmintic benzimidazole fenbendazole: enhanced inhibition of cytochrome P450 reactions by oxidized metabolites of the drug.
Murray M; Hudson AM; Yassa V
Chem Res Toxicol; 1992; 5(1):60-6. PubMed ID: 1581538
[TBL] [Abstract][Full Text] [Related]
35. Differences in cytochrome P450-mediated biotransformation of 1,2-dichlorobenzene by rat and man: implications for human risk assessment.
Hissink AM; Oudshoorn MJ; Van Ommen B; Haenen GR; Van Bladeren PJ
Chem Res Toxicol; 1996 Dec; 9(8):1249-56. PubMed ID: 8951226
[TBL] [Abstract][Full Text] [Related]
36. Induction of the male-specific cytochrome P450 3A2 in female rats by phenytoin.
Ghosal A; Sadrieh N; Reik L; Levin W; Thomas PE
Arch Biochem Biophys; 1996 Aug; 332(1):153-62. PubMed ID: 8806720
[TBL] [Abstract][Full Text] [Related]
37. Microsomal cytochrome P450 dependent oxidation of N-hydroxyguanidines, amidoximes, and ketoximes: mechanism of the oxidative cleavage of their C=N(OH) bond with formation of nitrogen oxides.
Jousserandot A; Boucher JL; Henry Y; Niklaus B; Clement B; Mansuy D
Biochemistry; 1998 Dec; 37(49):17179-91. PubMed ID: 9860831
[TBL] [Abstract][Full Text] [Related]
38. Phenobarbital induction of hepatic CYP2B1 and CYP2B2: pretranscriptional and post-transcriptional effects of gender, adult age, and phenobarbital dose.
Agrawal AK; Shapiro BH
Mol Pharmacol; 1996 Mar; 49(3):523-31. PubMed ID: 8643092
[TBL] [Abstract][Full Text] [Related]
39. Biotransformation of the anthraquinones emodin and chrysophanol by cytochrome P450 enzymes. Bioactivation to genotoxic metabolites.
Mueller SO; Stopper H; Dekant W
Drug Metab Dispos; 1998 Jun; 26(6):540-6. PubMed ID: 9616189
[TBL] [Abstract][Full Text] [Related]
40. Metabolism and excretion of S-conjugates derived from hexachlorobutadiene in the isolated perfused rat kidney.
Schrenk D; Dekant W; Henschler D
Mol Pharmacol; 1988 Sep; 34(3):407-12. PubMed ID: 3419428
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
